Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
Archil Jaliashvili, Co-owner, General Manager of SkinAI, Co-Chief Executive Officer at GeoBio Pharm, shared a post on LinkedIn about a recent article by Roberto Primi et al., published in Scientific Reports, adding:
“Interesting perspective.
This study shows that OHCA is not distributed evenly across a population – geography, age structure, population density and socioeconomic factors all influence where the burden is concentrated.
But there is another dimension we should consider: time and therapeutic availability.
If every minute matters, should we rethink how we equip EMS – particularly helicopters and other prehospital systems?
We need solutions that can bridge the patient to definitive hospital treatment: maintaining oxygen delivery during the critical transport window, when blood products or other advanced therapies may not be immediately available.
This is where a donor-independent oxygenation solution such as BHOC – Biological Hemoglobin Oxygen Carrier could play a complementary role – not replacing blood or hospital treatment, but supporting oxygen delivery and helping bridge the patient from the point of emergency to the hospital where definitive treatment can be delivered.
The future of emergency care may not only be about getting the patient to hospital faster.
It also about bringing therapeutic capability closer to the patient.
Because when every minute matters, time itself becomes a therapeutic resource.”
Title: Spatial inequalities in out-of-hospital cardiac arrest in Lombardy, Italy are associated with ageing, population density and low income
Authors: Roberto Primi, Stefania Bertazzon, Simona Villani, Sara Bendotti, Leila Ulmanova, Alessia Currao, Gianluca Marconi, Maurizio Migliari, Gabriele Mario Perotti, Enrico Baldi, Leonardo De Luca, Simone Savastano
Other posts featuring Archil Jaliashvili on Hemostasis Today.
-
Sep 23, 2026, 04:34David Akande: When Sickle Cell Crises Have No Clear Trigger
-
Sep 23, 2026, 04:13Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
-
Sep 23, 2026, 04:09Beth Psaila: Applications Now Open for the Gordon Research Conference on Megakaryocytes and Platelets
-
Sep 23, 2026, 03:27Abbie Newton: How Better Data Can Reduce Platelet Wastage
-
Sep 23, 2026, 03:01Suvro Sankha Datta: Rapid Blood Group Genotyping Using Gold Oligo Nanonet Assembly
-
Sep 23, 2026, 02:55Asghar Muhammad: Exploring New Ways to Expand Blood Transfusion Compatibility
-
Sep 23, 2026, 02:49Bianca Rocca: Personalized Cardiovascular Pharmacotherapy in the September 2026 EHJ Issue
-
Sep 23, 2026, 02:35Udaya RajBhandari: A Hidden Risk of Repeated Transfusions in β Thalassemia
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy